CONTINUING MEDICAL EDUCATION (CME). Emerging Treatments and Evolving Paradigms in HER2-Low Breast Cancer.
- Published in:
- Oncology (08909091), 2023, v. 37, n. 12, p. 496
- By:
- Publication type:
- Article
Works matching IS 08909091 AND DT 2023 AND VI 37 AND IP 12
Results: 6
1
2
Genomic Predictors Associated With Exceptional Response to Systemic Therapy in Advanced Pancreatic Cancer.
- Published in:
- Oncology (08909091), 2023, v. 37, n. 12, p. 488, doi. 10.46883/2023.25921008
- By:
- Publication type:
- Article
3
Danazol for the Treatment of Myelodysplastic Syndromes: A Systematic Review.
- Published in:
- Oncology (08909091), 2023, v. 37, n. 12, p. 480, doi. 10.46883/2023.25921009
- By:
- Publication type:
- Article
4
INTERVIEW. Impact of Sotorasib and Adagrasib in KRAS G12C--Mutated NSCLC.
- Published in:
- Oncology (08909091), 2023, v. 37, n. 12, p. 479
- Publication type:
- Article
5
Early Access to Electronic Health Records May Influence the Patient Experience.
- Published in:
- Oncology (08909091), 2023, v. 37, n. 12, p. 477, doi. 10.46883/2023.25921010
- By:
- Publication type:
- Article
6
2023 Year in Review: Topics in Hematology/Oncology.
- Published in:
- Oncology (08909091), 2023, v. 37, n. 12, p. 476
- By:
- Publication type:
- Article